Wei Ding

25PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei

|Jun 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.

R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox

|Feb 22, 2023
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.

Scott F Huntington, Stephen J Schuster, Wei Ding

|Sep 01, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

Paul J Hampel, Kari G Rabe, Timothy G Call

|Feb 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).

Youssef Salama, Fang Zhao, Jennifer L Oliveira

|Jan 29, 2022
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Rebecca L King, Alia Gupta, Paul J Kurtin

Pageof 5

Frequent Collaborators

20 joint publications

Sameer A Parikh

16 joint publications

Saad S Kenderian

13 joint publications

Kari G Rabe

11 joint publications

Yucai Wang